详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer

120| 认领 | 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

试验分期：

研究疾病/适应症：

研究类型：

研究负责人：

研究参与人：

研究单位： [1]Peking University Cancer Hospital & Institute [2]Cancer Hospital Chinese Acadamy of Medical Sciences,Beijing, Beijing, China, 100021 [3]Peking University First Hospital,Beijing, Beijing, China, 100034 [4]Peking University People's Hospital,Beijing, Beijing, China, 100044 [5]Beijing Friendship Hospital,Beijing, Beijing, China, 100050 [6]Xuanwu Hospital,Beijing, Beijing, China, 100053 [7]Beijing Cancer Hospital,Beijing, Beijing, China, 100142 [8]Beijing Hospital,Beijing, Beijing, China, 100730 [9]Chinese PLA General Hospital,Beijing, Beijing, China, 100853 [10]Zhongnan Hospital of Wuhan University,Wuhan, Hubei, China, 430071 [11]Nanjing General Hospital,Nanjing, Jiangsu, China, 210002 [12]The First Affiliated Hospital of Daliang Medical University,Daliang, Liaoning, China, 116011 [13]Qilu Hospital of Shandong University,Jinan, Shandong, China, 250012 [14]Zhejiang Cancer Hospital,Hangzhou, Zhejiang, China, 310022 [15]The First Affiliated Hospital of Wenzhou Medical University,Wenzhou, Zhejiang, China, 325000 [16]The Second Affiliated Hospital of Wenzhou Medical University,Wenzhou, Zhejiang, China, 325000

关键词： Gastric cancer Adjuvant chemotherapy S1 Oxaliplatin Survival

研究目的：

The purpose of the study is to evaluate the efficacy and safety of S-1 plus Oxaliplatin versus S-1 only as adjuvant chemotherapy after curative distal gastrectomy in patients with locally advanced gastric cancer.